Calpains and disease, N Engl J Med, vol.352, pp.2413-2436, 2005. ,
Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients, Hum Mutat, vol.29, pp.258-66, 2008. ,
The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B) ,
, Neurol Res, vol.32, pp.41-47, 2010.
Genetic variability and clinical spectrum of Chinese patients with limb-girdle muscular dystrophy type 2A, Muscle Nerve, vol.46, pp.723-732, 2012. ,
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A, Cell, vol.81, pp.27-40, 1995. ,
Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway, Hum Mol Genet, vol.14, pp.2125-2159, 2005. ,
Calpain 3: a key regulator of the sarcomere?, FEBS J, vol.273, pp.3427-3463, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01610048
Skeletal muscle-specific calpain is an intracellular Na + -dependent protease, J Biol Chem, vol.285, pp.22986-98, 2010. ,
A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy, Brain, vol.139, pp.2154-63, 2016. ,
Autosomal dominant calpainopathy due to heterozygous CAPN3 ,
, Muscle Nerve, vol.57, pp.679-83, 2018.
Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients, Ann Clin TranslNeurol, vol.5, pp.1574-87, 2018. ,
, 229th ENMC international workshop: limb girdle muscular dystrophies -nomenclature and reformed classification, vol.28, pp.702-712, 2017.
A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing, Eur J Hum Genet, vol.27, pp.349-52, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02434896
CAPN3 mutations in patients with idiopathic eosinophilic myositis, Ann Neurol, vol.59, pp.905-916, 2006. ,
Comparing targeted exome and whole exome approaches for genetic diagnosis of neuromuscular disorders, Appl Transl Genom, vol.7, pp.26-31, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01610017
A reliable targeted next-generation sequencing strategy for diagnosis of myopathies and muscular dystrophies, especially for the giant titin and nebulin genes, J Mol Diagn, vol.20, pp.533-582, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01800470
The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome), Neuromuscul Disord, vol.23, pp.1081-111, 2013. ,
HGVS recommendations for the description of sequence variants: 2016 update, Hum Mutat, vol.37, pp.564-573, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-02438000
A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay, Neuromuscul Disord, vol.17, pp.148-56, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01610045
Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders, Skelet Muscle, vol.1, p.34, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00651121
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-429, 2015. ,
0: the next generation in gene variant databases, den Dunnen JT LOVD, vol.2, pp.557-63, 2011. ,
ClinVar: improving access to variant interpretations and supporting evidence, Nucleic Acids Res, vol.46, pp.1062-1069, 2018. ,
Calpainopathy-a survey of mutations and polymorphisms, Am J Hum Genet, vol.64, pp.1524-1564, 1999. ,
Molecular diagnosis in LGMD2A: mutation analysis or protein testing?, Hum Mutat, vol.24, pp.52-62, 2004. ,
LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene, Brain, vol.128, pp.732-774, 2005. ,
Transcriptional and translational effects of intronic CAPN3 gene mutations, Hum Mutat, vol.31, pp.1658-69, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00613752
Eosinophils in hereditary and inflammatory myopathies, Acta Myol, vol.32, pp.148-53, 2013. ,
ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases, BMC Neurol, vol.15, p.172, 2015. ,
Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3, Hum Mol Genet, vol.20, pp.3331-3376, 2011. ,
Late-onset axial myopathy and camptocormia in a calpainopathy carrier, J Clin Neuromuscul Dis, vol.13, pp.209-222, 2012. ,
The diagnostic value of MRI pattern recognition in distal myopathies, Front Neurol, vol.9, p.456, 2018. ,
Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls, Muscle Nerve, vol.52, pp.163-73, 2015. ,
CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies, Neuromuscul Disord, vol.26, pp.504-514, 2016. ,
Expanding the phenotype of GMPPB mutations, Brain, vol.138, pp.836-880, 2015. ,
Next-generation sequencing approach to hyperCKemia: a 2-year cohort study, Neurol Genet, vol.5, p.352, 2019. ,
Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation, J Biol Chem, vol.293, pp.4056-70, 2018. ,
Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain, Biophys J, vol.80, pp.2590-2596, 2001. ,
Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system, J Biol Chem, vol.281, pp.18519-18550, 2006. ,
Dominant LGMD2A: alternative diagnosis or hidden digenism?, Brain, vol.140, p.7, 2017. ,
Reply: dominant LGMD2A: alternative diagnosis or hidden digenism?, Brain, vol.140, p.8, 2017. ,